Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmunity during lymphopenia: a two-hit model.

Tom Krupica1, Terry J Fry, Crystal L Mackall

  • 1Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA.

Clinical Immunology (Orlando, Fla.)
|June 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell Cycle Sensing Shapes Human T Cell Fate and Exhaustion Programs.

bioRxiv : the preprint server for biology·2026
Same author

Reduced CCL/Be-specific CD4+ T cells in CCL3-deficient or peptide-MHC II CAR-T cell-treated mice.

JCI insight·2026
Same author

CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results.

Journal for immunotherapy of cancer·2026
Same author

A single-cell multi-omics assay for simultaneous measurement of vector copy number and protein expression in CAR T cells.

Molecular therapy. Advances·2026
Same author

Cell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysis.

Cell·2026
Same author

Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy.

Blood cancer journal·2026
Same journal

A novel JAK1 mutation identified in a patient with severe atopic dermatitis phenotype: Mechanistic insights and IL-4Rα targeted therapy.

Clinical immunology (Orlando, Fla.)·2026
Same journal

VNN1 aggravates sepsis by promoting inflammation and oxidative stress through PPARγ signaling VNN1 in sepsis.

Clinical immunology (Orlando, Fla.)·2026
Same journal

Comparison between glioblastoma and brain metastases: How epigenetic remodeling can enhance immunotherapy.

Clinical immunology (Orlando, Fla.)·2026
Same journal

JAK-STAT3-MYC axis defines pathogenic stem cell-like memory CD4<sup>+</sup> T cells in rheumatoid arthritis.

Clinical immunology (Orlando, Fla.)·2026
Same journal

The baseline vaginal immune milieu is an important determinant of the inflammatory response induced by penile-vaginal sex.

Clinical immunology (Orlando, Fla.)·2026
Same journal

Adulthood diagnosis of Nijmegen breakage syndrome in twins with antibody deficiency clinical presentation.

Clinical immunology (Orlando, Fla.)·2026
See all related articles

Lymphopenia suspends immune tolerance, allowing T cells to attack self-antigens. A second insult, like inflammation or Treg depletion, can trigger autoimmune disease in lymphopenic individuals.

Area of Science:

  • Immunology
  • Autoimmunity
  • T cell biology

Background:

  • The immune system balances self-tolerance with pathogen response.
  • Lymphopenia temporarily suspends tolerance mechanisms, enabling T cell expansion.
  • This expansion can lead to autoimmunity if other factors are present.

Purpose of the Study:

  • To review settings where autoimmunity occurs with lymphopenia.
  • To propose a "two-hit" model for lymphopenia-induced autoimmunity.
  • To identify cofactors that trigger autoimmune disease during lymphopenia.

Main Methods:

  • Review of murine and human studies on autoimmunity in lymphopenic contexts.
  • Analysis of specific secondary insults contributing to autoimmunity.
  • Synthesis of findings into a proposed "two-hit" model.

Related Experiment Videos

Main Results:

  • Lymphopenia alone does not cause autoimmunity; a secondary insult is required.
  • Overproduction of IL-21, Treg depletion, and tissue inflammation are identified as key cofactors.
  • The "two-hit" model explains autoimmune disease development in lymphopenic hosts.

Conclusions:

  • Delineating cofactors provides insight into autoimmune disease pathophysiology.
  • Findings offer testable hypotheses for inducing tumor-specific autoimmunity in cancer patients.
  • Understanding these mechanisms is crucial for managing autoimmune conditions and cancer therapy.